4.7 Article

Ligand- and Structure-Based Virtual Screening for Clathrodin-Derived Human Voltage-Gated Sodium Channel Modulators

Journal

JOURNAL OF CHEMICAL INFORMATION AND MODELING
Volume 53, Issue 12, Pages 3223-3232

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/ci400505e

Keywords

-

Funding

  1. Slovenian Research Agency [P1-0208, Z1-5458]
  2. European Union [FP7-KBBE-2009-3-245137]

Ask authors/readers for more resources

Voltage-gated sodium channels (VGSC) are attractive targets for drug discovery because of the broad therapeutic potential of their modulators. On the basis of the structure of marine alkaloid clathrodin, we have recently discovered novel subtype-selective VGSC modulators I and II that were used as starting points for two different ligand-based virtual screening approaches for discovery of novel VGSC modulators. Similarity searching in the ZINC database of drug-like compounds based on compound I resulted in five state-dependent Na(v)1.3 and Na(v)1.7 modulators with improved activity compared to I (IC50 < 20 mu M). Compounds 2 and 16 that blocked sodium permeation in Na(v)1.7 with IC50 values of 7 and 9 mu M, respectively, are among the most potent clathrodin analogs discovered so far. In the case of compound II, 3D similarity searching in the same database was followed by docking of an enriched compound library into our human Na(v)1.4 open-pore homology model. Although some of the selected compounds, e.g., 31 and 32 displayed 21% and 22% inactivated state I-peak block of Na(v)1.4 at 10 mu M, respectively, none showed better Na(v)1.4 modulatory activity than compound II. Taken together, virtual screening yielded compounds 2 and 16, which represent novel scaffolds for the discovery of human Na(v)1.7 modulators.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Chemistry, Medicinal

Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment

Zan Toplak, Louise A. Hendrickx, Reham Abdelaziz, Xiaoyi Shi, Steve Peigneur, Tihomir Tomasic, Jan Tytgat, Lucija Peterlin-Masic, Luis A. Pardo

Summary: Research has shown the importance of ion channel expression in tumor progression, with Eag1 being overexpressed in many human tumors. However, finding selective inhibitors for Eag1 is challenging due to its structural similarities with the cardiac HERG channel. Structural differences between Eag1 and HERG channels may offer opportunities for selective targeting in cancer therapies.

MEDICINAL RESEARCH REVIEWS (2022)

Article Chemistry, Medicinal

Selective Monovalent Galectin-8 Ligands Based on 3-Lactoylgalactoside

Benedetta Girardi, Martina Manna, Sjors Van Klaveren, Tihomir Tomasic, Ziga Jakopin, Hakon Leffler, Ulf J. Nilsson, Daniel Ricklin, Janez Mravljak, Oliver Schwardt, Marko Anderluh

Summary: The study aimed to improve the affinity and target selectivity of a galectin-8 ligand by introducing modifications at positions 1 and 3 of the galactose, resulting in a promising lead for the development of new selective and potent ligands for galectin-8, highlighting its potential role in cell-based and in vivo studies.

CHEMMEDCHEM (2022)

Article Chemistry, Medicinal

Selective Galectin-8N Ligands: The Design and Synthesis of Phthalazinone-d-Galactals

Sjors van Klaveren, Anders P. Sundin, Ziga Jakopin, Marko Anderluh, Hakon Leffler, Ulf J. Nilsson, Tihomir Tomasic

Summary: The study reports phthalazinone-galactals that show excellent selectivity for the galectin-8N-terminal domain, a protein prevalent in both pathology and tissue distribution. The dissected structure-activity relationships and extensive molecular dynamics meta-analysis accompany the discovery of these selective galectin-8N ligands, which will facilitate the study of galectin-8 biology and may have pharmaceutical relevance in a wide range of galectin-8 associated pathologies.

CHEMMEDCHEM (2022)

Article Biochemistry & Molecular Biology

Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors

Bernarda Majc, Anamarija Habic, Metka Novak, Ana Rotter, Andrej Porcnik, Jernej Mlakar, Vera Zupunski, Ursa Pecar Fonovic, Damijan Knez, Nace Zidar, Stanislav Gobec, Janko Kos, Tamara Lah Turnsek, Anja Pislar, Barbara Breznik

Summary: This study found that cathepsin X is upregulated in human GBM tissues and localized in GBM cells, tumor-associated macrophages, and microglia. Selective cathepsin X inhibitors can decrease the viability of GBM cells and are colocalized with gamma-enolase, suggesting that cathepsin X is involved in GBM progression and could be a potential therapeutic target.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Cardiac & Cardiovascular Systems

Review: HCN Channels in the Heart

Anne-Sophie Depuydt, Steve Peigneur, Jan Tytgat

Summary: Pacemaker cells are crucial for the rhythm of the heart, and cardiovascular diseases and arrhythmias are major causes of hospital admissions and sudden death. The prevalence of arrhythmias will increase due to an aging population and risk factors. HCN channels, the molecular correlate of the pacemaker activity, have shown potential as targets for drug development to lower heart rate. However, there is still limited understanding of their pharmacology compared to other ion channels. Ivabradine is currently the only approved drug targeting HCN channels. This review focuses on the pacemaking process in the heart and summarizes current knowledge on HCN channels.

CURRENT CARDIOLOGY REVIEWS (2022)

Article Biochemistry & Molecular Biology

Kunitz-Type Peptides from Sea Anemones Protect Neuronal Cells against Parkinson's Disease Inductors via Inhibition of ROS Production and ATP-Induced P2X7 Receptor Activation

Aleksandra Kvetkina, Evgeny Pislyagin, Ekaterina Menchinskaya, Ekaterina Yurchenko, Rimma Kalina, Sergei Kozlovskiy, Leonid Kaluzhskiy, Alexander Menshov, Natalia Kim, Steve Peigneur, Jan Tytgat, Alexis Ivanov, Naira Ayvazyan, Elena Leychenko, Dmitry Aminin

Summary: This study investigated the neuroprotective effects of four peptides from sea anemones on Parkinson's disease. The peptides were found to inhibit PD inducers and reduce oxidative stress and inflammation. Furthermore, the study discovered that these peptides interact with the P2X7R channels, which are therapeutic targets for Parkinson's disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening

Elena M. Loi, Tihomir Tomasic, Cyril Balsollier, Kevin van Eekelen, Matjaz Weiss, Martina Gobec, Matthew G. Alteen, David J. Vocadlo, Roland J. Pieters, Marko Anderluh

Summary: In this study, a novel OGT inhibitor with a uridine mimetic scaffold was identified through virtual screening. The inhibitor showed promising activity in enzyme assays and provides a potential starting point for the development of OGT inhibitors with clinical applications.

MOLECULES (2022)

Article Oncology

Design of New Potent and Selective Thiophene-Based KV1.3 Inhibitors and Their Potential for Anticancer Activity

Spela Gubic, Louise Antonia Hendrickx, Xiaoyi Shi, Zan Toplak, Stefan Mozina, Kenny M. Van Theemsche, Ernesto Lopes Pinheiro-Junior, Steve Peigneur, Alain J. Labro, Luis A. Pardo, Jan Tytgat, Tihomir Tomasic, Lucija Peterlin Masic

Summary: In this article, a new class of potassium channel inhibitors is described, which selectively inhibits the K(V)1.3 channel and shows potential in inducing apoptosis and inhibiting cell proliferation. The K(V)1.3 channel has recently emerged as a target in cancer therapy. Through structural optimization, a novel K(V)1.3 inhibitor was designed and its potency and selectivity were investigated. The results showed that the new K(V)1.3 inhibitors effectively inhibited cancer cell proliferation and induced apoptosis.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Pharmacological Screening of Venoms from Five Brazilian Micrurus Species on Different Ion Channels

Jessica Matos Kleiz-Ferreira, Hans Bernaerts, Ernesto Lopes Pinheiro-Junior, Steve Peigneur, Russolina Benedeta Zingali, Jan Tytgat

Summary: Coral snake venoms from the Micrurus genus are a diverse collection of components that act on multiple targets. They are mainly composed of phospholipases A(2) and three-finger toxins, which cause neuromuscular blockade. In addition to these major toxin families, minor components also play a significant role in the venom's overall activity. The venoms of five Micrurus species from Brazil were found to act on different types of targets, with potential potassium channel inhibitory activity being a key feature of their envenomation strategy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

In Silico Discovery and Optimisation of a Novel Structural Class of Hsp90 C-Terminal Domain Inhibitors

Ziva Zajec, Jaka Dernovsek, Martina Gobec, Tihomir Tomasic

Summary: Hsp90 is a promising target for cancer treatment. The discovery of a novel class of Hsp90 CTD inhibitors through virtual screening provides new starting points for further development, showing enhanced antiproliferative activities in breast cancer and sarcoma cell lines.

BIOMOLECULES (2022)

Article Chemistry, Multidisciplinary

Computer-aided structure-based optimization of 4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine derivatives as DNA gyrase B inhibitors

Lucas J. Gutierrez, Marcela Vettorazzi, Jaka Dernovsek, Martina Durcik, Lucija Peterlin Masic, Tihomir Tomasic, Ricardo D. Enriz

Summary: In this study, we investigated the inhibitory activity of 4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine derivatives on bacterial DNA gyrase B (GyrB) through theoretical and experimental approaches. Our results revealed that QTAIM calculations can effectively quantify molecular interactions and determine the amino acids that interact with the ligands. Additionally, our simulations showed that this method can predict the affinity and potential activity of compounds that have not been synthesized.

NEW JOURNAL OF CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

ScrepYard: An online resource for disulfide-stabilized tandem repeat peptides

Junyu Liu, Michael Maxwell, Thom Cuddihy, Theo Crawford, Madeline Bassetti, Cameron Hyde, Steve Peigneur, Jan Tytgat, Eivind A. B. Undheim, Mehdi Mobli

Summary: Receptor avidity through multivalency is difficult to engineer in synthetic molecules, but can be found in natural bivalent antibodies. The discovery of bivalent venom peptides with tandem repeat domains has provided insight into multivalency in biomolecules. ScrepYard, an online resource, assists in identifying SCREP sequences and characterizing this emerging class of biomolecules.

PROTEIN SCIENCE (2023)

Article Biochemistry & Molecular Biology

Structure-Function Studies of Sponge-Derived Compounds on the Cardiac CaV3.1 Channel

Anne-Sophie Depuydt, Piyush A. Patel, Zan Toplak, Chinmaya Bhat, Manuela Voracova, Irene Etelainen, Fiammetta Vitulano, Tanja Bruun, Antti Lempinen, Nives Hribernik, Eero Maki-Lohiluoma, Louise Hendrickx, Ernesto Lopes Pinheiro-Junior, Tihomir Tomasic, Lucija Peterlin Masic, Jari Yli-Kauhaluoma, Paula Kiuru, Jan Tytgat, Steve Peigneur

Summary: T-type calcium channels play important roles in cardiac function, and their dysfunction is associated with pathological conditions. In this study, a new class of T-type calcium channel inhibitors was discovered and their mechanism of action was investigated. These findings provide new insights into drug design and the interaction of drugs with T-type calcium channels.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Multidisciplinary

Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1,-3 and-8 inhibitors

Sjors van Klaveren, Jaka Dernovsek, Ziga Jakopin, Marko Anderluh, Hakon Leffler, Ulf J. Nilsson, Tihomir Tomasic

Summary: Galectins are proteins that can bind to galactosides and play a crucial role in drug discovery. The authors have designed a series of aromatic 3-triazolyl-1-thiogalactosides and evaluated their binding affinities with different Galectins.

RSC ADVANCES (2022)

No Data Available